Missouri Senate Bill SB1166

Missouri 2022 Regular Session

• Introduced: 2/23/22
• Refer: 3/10/22

Caption

Enacts provisions relating to coverage of diagnostic examinations for breast cancer under certain health benefit plans

Impact

The legislation proposes to amend existing statutes in chapter 376 of the Revised Statutes of Missouri, potentially affecting numerous health benefit plans across the state. By mandating that diagnostic examinations be covered under similar cost-sharing terms as mammograms, the bill seeks to alleviate the financial burden on those needing such examinations. This change aims to promote early detection and treatment of breast cancer, thereby improving health outcomes for residents.

Summary

Senate Bill 1166 aims to enhance the coverage of diagnostic examinations for breast cancer within specific health benefit plans in Missouri. Introduced by Senator Gannon, the bill stipulates that health carriers offering plans after January 1, 2023, must ensure that the cost-sharing requirements for diagnostic examinations for breast cancer are as favorable as those for low-dose mammography screenings. This provision intends to broaden financial access for individuals requiring essential diagnostic services for breast cancer evaluation.

Contention

While the bill has garnered support for its focus on women's health and financial accessibility, there may be concerns regarding its implications for insurance carriers and the overall impact on premium costs. Critics may argue that increased coverage provisions could lead to higher premiums for consumers, potentially offsetting the benefits of improved access to diagnostic services. Ensuring equitable health care access might come at a cost, raising discussions among stakeholders about the balance between coverage requirements and insurance sustainability.